Mehra Uneek 4
4 · 4D Molecular Therapeutics, Inc. · Filed Oct 3, 2023
Insider Transaction Report
Form 4
Mehra Uneek
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2023-10-01+229,634→ 229,634 totalExercise: $12.73Exp: 2033-09-30→ Common Stock (229,634 underlying)
Footnotes (1)
- [F1]The stock option will vest with respect to 25% of the total number of the underlying shares on September 11, 2024, and the remaining shares will vest in equal monthly installments over the following three-year period, such that the stock option will be fully vested on September 11, 2027, subject to the Reporting Person continuing to be a service provider to Issuer through each vesting date.